$CNFN Cashflow Statement | Understand Stock

$CNFN

$0.35 -$0.54 (60.6%) Close

$CNFN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2020 1 months to Jan 31, 2021
Cash flows from operating activities
Net income (loss)
Net loss
Net loss from continuing operations
Depreciation and amortization
Impairment charge
Amortization of right of use asset
Impairment of goodwill
Bad debt expense
Stock compensation expense
Gain on property and equipment
Gain on extinguishment of debt
Loss on conversion of debt
Impairment Charge on Right of Use Asset
Impairment of investments
Unrealized loss (gain) on marketable securities
Proceeds from (Payments to) Noncontrolling Interests
Impairment of long-term asset
Forgiveness of SBA PPP loan
Loss on extinguishment of debt
Amortization of debt discount
Contingent consideration
Loss on conversion of accrued interest
Changes in operating assets and liabilities
Net cash (used in) provided by operating activities
Accounts receivable, net
Inventories, net
Prepaid expenses and other assets
Other assets
Accounts payable and accrued expenses
Deferred revenue
Payments made in advance of securities date
Right of use liability, net
Net cash used in operating activities from continuing operations
Net cash provided by operating activities from discontinued operations

Cash flows from investing activities
Cash acquired pursuant to business combination
Sale of assets held for sale
Payments for investment
Cash acquired in acquisition of CNP operating, LLC
Purchase of property and equipment, net
Net cash used in investing activities from continuing operations
Net cash used in investing activities from discontinued operations
Net cash used in investing activities

Cash flows from financing activities
Net advances from related parties
Proceeds from (Repayments of) Related Party Debt
Proceeds from Notes Payable
Increase (Decrease) in Due to Related Parties
Repayments of Notes Payable
Proceeds from Contributed Capital
Proceeds from sale of common stock
Proceeds from Warrant Exercises
Capital contributions of joint venture partner
Net cash provided by financing activities from continuing operations
Net cash used in financing activities from discontinued operations
Net cash used provided by (used in) financing activities
Cash and restricted cash, beginning of the period

Net change in cash and cash equivalents
Cash and restricted cash at beginning of year
Cash and restricted cash at end of year
Cash at beginning of year
Restricted cash at beginning of year
Cash at end of year
Restricted cash at end of year
Supplemental disclosure of cash flow information
Cash paid for income taxes
Cash paid for interest
Supplemental disclosure of non-cash investing and financing activities
Due to seller and contingent consideration pursuant to business combination
Conversion of accrued preferred stock interest into shares
Right of use asset and liability
Warrants issued with promissory notes
Payment of CSIS debt by shareholder
Issuance of common stock sold in previous year
Investments received for services
Issuance common stock for acquisition of CNP Operating, LLC
Right of use asset
Accrual of preferred stock interest
Purchase of equipment with notes payable
Settlement of accounts payable with sale of equipment
Modification fee and conversion of accrued interest into shares
Issuance of common stock pursuant to assets acquisition

Comments